Losers At Healthcare: Synageva BioPharma (NASDAQ:GEVA), Auspex Pharmaceuticals (NASDAQ:ASPX), ImmunoGen (NASDAQ:IMGN), Infinity Pharmaceuticals Inc. (NASDAQ:INFI)

Synageva BioPharma Corp (NASDAQ:GEVA) last released its earnings data on Friday, May 2nd. The company reported ($1.16) earnings per share for the quarter, beating the analysts’ consensus estimate of ($1.19) by $0.03. Analysts expect that Synageva BioPharma Corp will post $-5.90 EPS for the current fiscal year. Synageva BioPharma Corp (NASDAQ:GEVA)stock performance was 5.87% in last session and finished the day at $ 85.40. Traded … Continue reading Losers At Healthcare: Synageva BioPharma (NASDAQ:GEVA), Auspex Pharmaceuticals (NASDAQ:ASPX), ImmunoGen (NASDAQ:IMGN), Infinity Pharmaceuticals Inc. (NASDAQ:INFI)

Biotech Unusual Volume: Zalicus Inc (NASDAQ:ZLCS), ImmunoGen (NASDAQ:IMGN), Transition Therapeutics (NASDAQ:TTHI), Lpath (NASDAQ:LPTN)

Zalicus Inc (NASDAQ:ZLCS) will merge with Epirus Biopharmaceuticals in an all-stock transaction. Zalicus will be known as Epirus and will operate under the latter company’s management team led by Amit Munshi as president and CEO. Current Zalicus Inc (NASDAQ:ZLCS) stockholders will own approximately 19% of the company. The merger will create a publicly-traded company listed on the NASDAQ. Zalicus Inc (NASDAQ:ZLCS) stock performance was 31.07% … Continue reading Biotech Unusual Volume: Zalicus Inc (NASDAQ:ZLCS), ImmunoGen (NASDAQ:IMGN), Transition Therapeutics (NASDAQ:TTHI), Lpath (NASDAQ:LPTN)

Biotech bullish Stocks: ImmunoGen (NASDAQ:IMGN), OXiGENE Inc (NASDAQ:OXGN), BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Celldex Therapeutics (NASDAQ:CLDX)

Shares of ImmunoGen Inc. (NASDAQ:IMGN), a biopharmaceutical company focused on developing therapies to fight cancer, advanced as much as 15% after research firm Canaccord Genuity initiated coverage on the company. ImmunoGen, Inc. (NASDAQ:IMGN) stock performance was 11.02% in last session and finished the day at $14.21. Traded volume was 2.85million shares in the last session and the average volume of the stock remained 858.46K shares. … Continue reading Biotech bullish Stocks: ImmunoGen (NASDAQ:IMGN), OXiGENE Inc (NASDAQ:OXGN), BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Celldex Therapeutics (NASDAQ:CLDX)

Stock Highlights: ImmunoGen, Inc. (NASDAQ:IMGN), Huntington Bancshares Incorporated (NASDAQ:HBAN), Ohio Valley Banc Corp. (NASDAQ:OVBC), SMTP, Inc. (NASDAQ:SMTP), Gol Linhas Aereas Inteligentes (NYSE:GOL)

On Oct. 28, Ventana Medical Systems, Inc. announced it has entered into an agreement with ImmunoGen, Inc. (NASDAQ:IMGN) to collaborate on the development of biomarker assays and a companion diagnostic immunohistochemistry (IHC) test for one or more of ImmunoGen’s product candidates. ImmunoGen, Inc. (NASDAQ:IMGN) belongs to Healthcare sector. Its weekly performance is 5.83%. On last trading day company shares ended up $9.26. ImmunoGen, Inc. (NASDAQ:IMGN) … Continue reading Stock Highlights: ImmunoGen, Inc. (NASDAQ:IMGN), Huntington Bancshares Incorporated (NASDAQ:HBAN), Ohio Valley Banc Corp. (NASDAQ:OVBC), SMTP, Inc. (NASDAQ:SMTP), Gol Linhas Aereas Inteligentes (NYSE:GOL)

Market Movers : ImmunoGen, Inc. (NASDAQ:IMGN), Ford Motor Company (NYSE:F), AT&T, Inc. (NYSE:T), Stanley Black & Decker, Inc. (NYSE:SWK), Computer Programs & Systems Inc. (NASDAQ:CPSI)

On Oct 10, ImmunoGen, Inc. (NASDAQ:IMGN) announced that the Company will host a conference call at 8:00 a.m. ET on Friday October 24 2014 to discuss ImmunoGen’s financial results for the three-month period ended September 30 2014 the first quarter of its 2015 fiscal year. ImmunoGen, Inc. (NASDAQ:IMGN) belongs to Healthcare sector. Its weekly performance is 2.74%. On last trading day company shares ended up … Continue reading Market Movers : ImmunoGen, Inc. (NASDAQ:IMGN), Ford Motor Company (NYSE:F), AT&T, Inc. (NYSE:T), Stanley Black & Decker, Inc. (NYSE:SWK), Computer Programs & Systems Inc. (NASDAQ:CPSI)

Stocks in Focus : LookSmart, Ltd. (NASDAQ:LOOK), SandRidge Energy, Inc. (NYSE:SD), Apple Inc. (NASDAQ:AAPL), Montage Technology Group Limited (NASDAQ:MONT), ImmunoGen, Inc. (NASDAQ:IMGN)

LookSmart, Ltd. (NASDAQ:LOOK) gave back some of the gains it accumulated earlier when speculators moved in the stock following Facebook Inc (FB)’s launch of Atlas. The stock declined 10.2% to $2.20 Tuesday. Facebook announced the launching of Atlas, an online marketing service that allows brand to achieve targeted ads on the Web and mobile platforms. The move led to speculations that LOOK and other companies … Continue reading Stocks in Focus : LookSmart, Ltd. (NASDAQ:LOOK), SandRidge Energy, Inc. (NYSE:SD), Apple Inc. (NASDAQ:AAPL), Montage Technology Group Limited (NASDAQ:MONT), ImmunoGen, Inc. (NASDAQ:IMGN)